Digital Health Global

APRIL 17, 2024

This new fund underscores the firm’s continued commitment to driving innovation and elevating health globally through investments in digital health, medical devices, life sciences, and tech-enabled care delivery. For more information, visit [link]. Contacts SpringTide Communications josh@springtide.com

Life Science 88

Life Science BioTech Healthcare Innovation Digital Health 88

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.

BioTech 107

BioTech Life Science Drug Development Patient Experience 107

Health Populi

MARCH 11, 2021

Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.

Health Policy 245

Health Policy Medicare Pharmaceuticals Life Science 245

Healthcare IT Today

NOVEMBER 20, 2022

A joint study by Omada Health, Rock Health, and the Digital Medicine Society, based on a survey of employers, payers and benefit consultants, found that 90% of purchasers view virtual care as a high priority , and the majority are willing to adopt innovative approaches, but few have a real understanding of what virtual care is.

eCare 52

eCare BioTech Primary Care Life Science 52

Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. In a recent review paper appeared on Nature , Mittermaier et al. in 2010 to 11.4%

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Lloyd Price

FEBRUARY 24, 2019

‘Connected’ medical devices give patients greater control over their health data, and in turn enable doctors to use the data to prompt beneficial patient behaviour. Policymakers and regulators must keep pace with the innovations emerging across the industry.

Life Science 49

Life Science BioTech Mobile Health Solutions Pharmaceuticals 49